Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Yingtong Lin"'
Autor:
Keming Lin, Baijin Xia, Xuemei Wang, Xin He, Mo Zhou, Yingtong Lin, Yidan Qiao, Rong Li, Qier Chen, Yuzhuang Li, Jinzhu Feng, Tao Chen, Cancan Chen, Xinyu Li, Hui Zhang, Lijuan Lu, Bingfeng Liu, Xu Zhang
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Chimeric antigen receptor T (CAR-T) cell therapy, as an emerging anti-tumor treatment, has garnered extensive attention in the study of targeted therapy of multiple tumor-associated antigens in hepatocellular carcinoma (HCC). Howe
Externí odkaz:
https://doaj.org/article/ecc7adc80b2848708c3915de61119331
Autor:
Tao Chen, Jieyi Deng, Yongli Zhang, Bingfeng Liu, Ruxin Liu, Yiqiang Zhu, Mo Zhou, Yingtong Lin, Baijin Xia, Keming Lin, Xiancai Ma, Hui Zhang
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-21 (2024)
Abstract Background Chimeric antigen receptor-T (CAR-T) cells therapy is one of the novel immunotherapeutic approaches with significant clinical success. However, their applications are limited because of long preparation time, high cost, and interpe
Externí odkaz:
https://doaj.org/article/9511fe7f52634905b73cd1ce394d7ce7
The efficacy of acupuncture therapies in cervical spondylotic radiculopathy: A network meta-analysis
Publikováno v:
Heliyon, Vol 10, Iss 11, Pp e31793- (2024)
Objective: To evaluate the efficacy of acupuncture-related therapy in the Bayesian setting by means of a network Meta-analysis. Methods: Relevant clinical randomized controlled trials(RCTs) of acupuncture-related therapy for Cervical Spondylotic Radi
Externí odkaz:
https://doaj.org/article/88c63fbd4e0b4f53988fe093acdcb508
Autor:
Baijin Xia, Keming Lin, Xuemei Wang, FeiLi Chen, Mo Zhou, Yuzhuang Li, Yingtong Lin, Yidan Qiao, Rong Li, Wanying Zhang, Xin He, Fan Zou, Linghua Li, Lijuan Lu, Cancan Chen, WenYu Li, Hui Zhang, Bingfeng Liu
Publikováno v:
Molecular Therapy: Oncolytics, Vol 30, Iss , Pp 86-102 (2023)
T cell lymphoma (TCL) is a highly heterogeneous group of diseases with a poor prognosis and low 5-year overall survival rate. The current therapeutic regimens have relatively low efficacy rates. Clinical studies of single-target chimeric antigen rece
Externí odkaz:
https://doaj.org/article/8bd13c8d62c349188e2873e52b71a5cb
Autor:
Xiantao Zhang, Shijian Wu, Jie Liu, Ran Chen, Yongli Zhang, Yingtong Lin, Zhihui Xi, Jieyi Deng, Zeyu Pu, Chaofeng Liang, Jinzhu Feng, Rong Li, Keming Lin, Mo Zhou, Yingying Liu, Xu Zhang, Bingfeng Liu, Yiwen Zhang, Xin He, Hui Zhang
Publikováno v:
Advanced Science, Vol 10, Iss 27, Pp n/a-n/a (2023)
Abstract Because of the rapid mutation and high airborne transmission of SARS‐CoV‐2, a universal vaccine preventing the infection in the upper respiratory tract is particularly urgent. Here, a mosaic receptor‐binding domain (RBD) nanoparticle (
Externí odkaz:
https://doaj.org/article/5a261decdfe94b549268ee1651b4491d
Autor:
Ran Chen, Xiantao Zhang, Yaochang Yuan, Xiaohui Deng, Bolin Wu, Zhihui Xi, Guanwen Wang, Yingtong Lin, Rong Li, Xuemei Wang, Fan Zou, Liting Liang, Haiping Yan, Chaofeng Liang, Yuzhuang Li, Shijian Wu, Jieyi Deng, Mo Zhou, Xu Zhang, Congrong Li, Xiuqing Bu, Yi Peng, Changwen Ke, Kai Deng, Xin He, Yiwen Zhang, Zhenhai Zhang, Ting Pan, Hui Zhang
Publikováno v:
Advanced Science, Vol 9, Iss 11, Pp n/a-n/a (2022)
Abstract The SARS‐CoV‐2 Delta (B.1.617.2) strain is a variant of concern (VOC) that has become the dominant strain worldwide in 2021. Its transmission capacity is approximately twice that of the original strain, with a shorter incubation period a
Externí odkaz:
https://doaj.org/article/fc8f318a08d5408c82499f5a52c132c6
Autor:
Fei Yu, Ting Pan, Feng Huang, Ruosu Ying, Jun Liu, Huimin Fan, Junsong Zhang, Weiwei Liu, Yingtong Lin, Yaochang Yuan, Tao Yang, Rong Li, Xu Zhang, Xi Lv, Qianyu Chen, Anqi Liang, Fan Zou, Bingfeng Liu, Fengyu Hu, Xiaoping Tang, Linghua Li, Kai Deng, Xin He, Hui Zhang, Yiwen Zhang, Xiancai Ma
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Since the outbreak of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), public health worldwide has been greatly threatened. The development of an effective treatment for this infection is
Externí odkaz:
https://doaj.org/article/9f6d477cfb394e8e9d3488b192945897
Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
Autor:
Fan Zou, Lijuan Lu, Jun Liu, Baijin Xia, Wanying Zhang, Qifei Hu, Weiwei Liu, Yiwen Zhang, Yingtong Lin, Shuliang Jing, Mei Huang, Bifen Huang, Bingfeng Liu, Hui Zhang
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
The inhibitory receptors PD-1, Tim-3 and Lag-3 act as negative feedback regulators of T cell responses. Here the authors improve CAR T cell antitumor efficacy by triple knockdown of these receptors, show it requires CD56, and correlate CD56-mediated
Externí odkaz:
https://doaj.org/article/62ecd82ea5c54588adc2d3e0f20f49a1
Autor:
Xinfeng Xu, Yingtong Lin, Xiaoyun Zeng, Chan Yang, Siqin Duan, Liqiong Ding, Wanzhen Lu, Jian Lin, Xiaoyan Pan, Xiancai Ma, Shuwen Liu
Publikováno v:
Cells, Vol 11, Iss 15, p 2331 (2022)
At present, the barrier to HIV-1 functional cure is the persistence of HIV-1 reservoirs. The “shock (reversing latency) and kill (antiretroviral therapy)” strategy sheds light on reducing or eliminating the latent reservoir of HIV-1. However, the
Externí odkaz:
https://doaj.org/article/25274a6ce9b9451883f6472a506338cd
Autor:
Shaoying Zhang, Kang Wu, Yufeng Liu, Yingtong Lin, Xu Zhang, Jie Zhou, Hui Zhang, Ting Pan, Yongshui Fu
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156549 (2016)
Myeloid-derived suppressor cells (MDSCs) have been known to be a key factor in the regulation of the immune system under numerous conditions such as tumors, infections, autoimmune diseases, and transplantations. In contrast to the proposed deleteriou
Externí odkaz:
https://doaj.org/article/9dce4f75c22445858a6dd12063c6c724